Table of Content

1 Pregabalin Market Overview
1.1 Product Overview and Scope of Pregabalin
1.2 Pregabalin Segment by Type
1.2.1 Global Pregabalin Market Value Comparison by Type (2024-2034)
1.2.2 Tablet
1.2.3 Capsule
1.2.4 Oral Solution
1.3 Pregabalin Segment by Application
1.3.1 Global Pregabalin Market Value by Application: (2024-2034)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Pregabalin Market Size Estimates and Forecasts
1.4.1 Global Pregabalin Revenue 2018-2034
1.4.2 Global Pregabalin Sales 2018-2034
1.4.3 Global Pregabalin Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Pregabalin Market Competition by Manufacturers
2.1 Global Pregabalin Sales Market Share by Manufacturers (2018-2024)
2.2 Global Pregabalin Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Pregabalin Average Price by Manufacturers (2018-2024)
2.4 Global Pregabalin Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Pregabalin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pregabalin, Product Type & Application
2.7 Pregabalin Market Competitive Situation and Trends
2.7.1 Pregabalin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pregabalin Players Market Share by Revenue
2.7.3 Global Pregabalin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pregabalin Retrospective Market Scenario by Region
3.1 Global Pregabalin Market Size by Region: 2018 Versus 2022 Versus 2034
3.2 Global Pregabalin Global Pregabalin Sales by Region: 2018-2034
3.2.1 Global Pregabalin Sales by Region: 2018-2024
3.2.2 Global Pregabalin Sales by Region: 2024-2034
3.3 Global Pregabalin Global Pregabalin Revenue by Region: 2018-2034
3.3.1 Global Pregabalin Revenue by Region: 2018-2024
3.3.2 Global Pregabalin Revenue by Region: 2024-2034
3.4 North America Pregabalin Market Facts & Figures by Country
3.4.1 North America Pregabalin Market Size by Country: 2018 VS 2022 VS 2034
3.4.2 North America Pregabalin Sales by Country (2018-2034)
3.4.3 North America Pregabalin Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pregabalin Market Facts & Figures by Country
3.5.1 Europe Pregabalin Market Size by Country: 2018 VS 2022 VS 2034
3.5.2 Europe Pregabalin Sales by Country (2018-2034)
3.5.3 Europe Pregabalin Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pregabalin Market Facts & Figures by Country
3.6.1 Asia Pacific Pregabalin Market Size by Country: 2018 VS 2022 VS 2034
3.6.2 Asia Pacific Pregabalin Sales by Country (2018-2034)
3.6.3 Asia Pacific Pregabalin Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pregabalin Market Facts & Figures by Country
3.7.1 Latin America Pregabalin Market Size by Country: 2018 VS 2022 VS 2034
3.7.2 Latin America Pregabalin Sales by Country (2018-2034)
3.7.3 Latin America Pregabalin Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pregabalin Market Facts & Figures by Country
3.8.1 Middle East and Africa Pregabalin Market Size by Country: 2018 VS 2022 VS 2034
3.8.2 Middle East and Africa Pregabalin Sales by Country (2018-2034)
3.8.3 Middle East and Africa Pregabalin Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Pregabalin Sales by Type (2018-2034)
4.1.1 Global Pregabalin Sales by Type (2018-2024)
4.1.2 Global Pregabalin Sales by Type (2024-2034)
4.1.3 Global Pregabalin Sales Market Share by Type (2018-2034)
4.2 Global Pregabalin Revenue by Type (2018-2034)
4.2.1 Global Pregabalin Revenue by Type (2018-2024)
4.2.2 Global Pregabalin Revenue by Type (2024-2034)
4.2.3 Global Pregabalin Revenue Market Share by Type (2018-2034)
4.3 Global Pregabalin Price by Type (2018-2034)
5 Segment by Application
5.1 Global Pregabalin Sales by Application (2018-2034)
5.1.1 Global Pregabalin Sales by Application (2018-2024)
5.1.2 Global Pregabalin Sales by Application (2024-2034)
5.1.3 Global Pregabalin Sales Market Share by Application (2018-2034)
5.2 Global Pregabalin Revenue by Application (2018-2034)
5.2.1 Global Pregabalin Revenue by Application (2018-2024)
5.2.2 Global Pregabalin Revenue by Application (2024-2034)
5.2.3 Global Pregabalin Revenue Market Share by Application (2018-2034)
5.3 Global Pregabalin Price by Application (2018-2034)
6 Key Companies Profiled
6.1 ZCL Chemicals
6.1.1 ZCL Chemicals Corporation Information
6.1.2 ZCL Chemicals Description and Business Overview
6.1.3 ZCL Chemicals Pregabalin Sales, Revenue and Gross Margin (2018-2024)
6.1.4 ZCL Chemicals Pregabalin Product Portfolio
6.1.5 ZCL Chemicals Recent Developments/Updates
6.2 Olon S.p.A.
6.2.1 Olon S.p.A. Corporation Information
6.2.2 Olon S.p.A. Description and Business Overview
6.2.3 Olon S.p.A. Pregabalin Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Olon S.p.A. Pregabalin Product Portfolio
6.2.5 Olon S.p.A. Recent Developments/Updates
6.3 AASraw Biochemical Technology
6.3.1 AASraw Biochemical Technology Corporation Information
6.3.2 AASraw Biochemical Technology Description and Business Overview
6.3.3 AASraw Biochemical Technology Pregabalin Sales, Revenue and Gross Margin (2018-2024)
6.3.4 AASraw Biochemical Technology Pregabalin Product Portfolio
6.3.5 AASraw Biochemical Technology Recent Developments/Updates
6.4 Changzhou Pharmaceutical Factory (CPF)
6.4.1 Changzhou Pharmaceutical Factory (CPF) Corporation Information
6.4.2 Changzhou Pharmaceutical Factory (CPF) Description and Business Overview
6.4.3 Changzhou Pharmaceutical Factory (CPF) Pregabalin Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Changzhou Pharmaceutical Factory (CPF) Pregabalin Product Portfolio
6.4.5 Changzhou Pharmaceutical Factory (CPF) Recent Developments/Updates
6.5 Almelo Pvt. Ltd.
6.5.1 Almelo Pvt. Ltd. Corporation Information
6.5.2 Almelo Pvt. Ltd. Description and Business Overview
6.5.3 Almelo Pvt. Ltd. Pregabalin Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Almelo Pvt. Ltd. Pregabalin Product Portfolio
6.5.5 Almelo Pvt. Ltd. Recent Developments/Updates
6.6 Divi’s Laboratories
6.6.1 Divi’s Laboratories Corporation Information
6.6.2 Divi’s Laboratories Description and Business Overview
6.6.3 Divi’s Laboratories Pregabalin Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Divi’s Laboratories Pregabalin Product Portfolio
6.6.5 Divi’s Laboratories Recent Developments/Updates
6.7 Angels Pharma
6.6.1 Angels Pharma Corporation Information
6.6.2 Angels Pharma Description and Business Overview
6.6.3 Angels Pharma Pregabalin Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Angels Pharma Pregabalin Product Portfolio
6.7.5 Angels Pharma Recent Developments/Updates
6.8 ARITE Pharmaceutical
6.8.1 ARITE Pharmaceutical Corporation Information
6.8.2 ARITE Pharmaceutical Description and Business Overview
6.8.3 ARITE Pharmaceutical Pregabalin Sales, Revenue and Gross Margin (2018-2024)
6.8.4 ARITE Pharmaceutical Pregabalin Product Portfolio
6.8.5 ARITE Pharmaceutical Recent Developments/Updates
6.9 BAL Pharma
6.9.1 BAL Pharma Corporation Information
6.9.2 BAL Pharma Description and Business Overview
6.9.3 BAL Pharma Pregabalin Sales, Revenue and Gross Margin (2018-2024)
6.9.4 BAL Pharma Pregabalin Product Portfolio
6.9.5 BAL Pharma Recent Developments/Updates
6.10 Bazayan
6.10.1 Bazayan Corporation Information
6.10.2 Bazayan Description and Business Overview
6.10.3 Bazayan Pregabalin Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Bazayan Pregabalin Product Portfolio
6.10.5 Bazayan Recent Developments/Updates
6.11 Aurobindo Pharma
6.11.1 Aurobindo Pharma Corporation Information
6.11.2 Aurobindo Pharma Pregabalin Description and Business Overview
6.11.3 Aurobindo Pharma Pregabalin Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Aurobindo Pharma Pregabalin Product Portfolio
6.11.5 Aurobindo Pharma Recent Developments/Updates
6.12 Hikal
6.12.1 Hikal Corporation Information
6.12.2 Hikal Pregabalin Description and Business Overview
6.12.3 Hikal Pregabalin Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Hikal Pregabalin Product Portfolio
6.12.5 Hikal Recent Developments/Updates
6.13 Glenmark Life Sciences
6.13.1 Glenmark Life Sciences Corporation Information
6.13.2 Glenmark Life Sciences Pregabalin Description and Business Overview
6.13.3 Glenmark Life Sciences Pregabalin Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Glenmark Life Sciences Pregabalin Product Portfolio
6.13.5 Glenmark Life Sciences Recent Developments/Updates
6.14 Dongbang FTL
6.14.1 Dongbang FTL Corporation Information
6.14.2 Dongbang FTL Pregabalin Description and Business Overview
6.14.3 Dongbang FTL Pregabalin Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Dongbang FTL Pregabalin Product Portfolio
6.14.5 Dongbang FTL Recent Developments/Updates
6.15 Teva Pharmaceutical Industries
6.15.1 Teva Pharmaceutical Industries Corporation Information
6.15.2 Teva Pharmaceutical Industries Pregabalin Description and Business Overview
6.15.3 Teva Pharmaceutical Industries Pregabalin Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Teva Pharmaceutical Industries Pregabalin Product Portfolio
6.15.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.16 Divi’s Laboratories
6.16.1 Divi’s Laboratories Corporation Information
6.16.2 Divi’s Laboratories Pregabalin Description and Business Overview
6.16.3 Divi’s Laboratories Pregabalin Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Divi’s Laboratories Pregabalin Product Portfolio
6.16.5 Divi’s Laboratories Recent Developments/Updates
6.17 Chemo Iberica
6.17.1 Chemo Iberica Corporation Information
6.17.2 Chemo Iberica Pregabalin Description and Business Overview
6.17.3 Chemo Iberica Pregabalin Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Chemo Iberica Pregabalin Product Portfolio
6.17.5 Chemo Iberica Recent Developments/Updates
6.18 Maps Laboratories
6.18.1 Maps Laboratories Corporation Information
6.18.2 Maps Laboratories Pregabalin Description and Business Overview
6.18.3 Maps Laboratories Pregabalin Sales, Revenue and Gross Margin (2018-2024)
6.18.4 Maps Laboratories Pregabalin Product Portfolio
6.18.5 Maps Laboratories Recent Developments/Updates
6.19 Laurus Labs
6.19.1 Laurus Labs Corporation Information
6.19.2 Laurus Labs Pregabalin Description and Business Overview
6.19.3 Laurus Labs Pregabalin Sales, Revenue and Gross Margin (2018-2024)
6.19.4 Laurus Labs Pregabalin Product Portfolio
6.19.5 Laurus Labs Recent Developments/Updates
6.20 Zhejiang Huahai Pharmaceutical
6.20.1 Zhejiang Huahai Pharmaceutical Corporation Information
6.20.2 Zhejiang Huahai Pharmaceutical Pregabalin Description and Business Overview
6.20.3 Zhejiang Huahai Pharmaceutical Pregabalin Sales, Revenue and Gross Margin (2018-2024)
6.20.4 Zhejiang Huahai Pharmaceutical Pregabalin Product Portfolio
6.20.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
6.21 Vasudha Pharma Chem
6.21.1 Vasudha Pharma Chem Corporation Information
6.21.2 Vasudha Pharma Chem Pregabalin Description and Business Overview
6.21.3 Vasudha Pharma Chem Pregabalin Sales, Revenue and Gross Margin (2018-2024)
6.21.4 Vasudha Pharma Chem Pregabalin Product Portfolio
6.21.5 Vasudha Pharma Chem Recent Developments/Updates
6.22 Sun Pharmaceutical Industries
6.22.1 Sun Pharmaceutical Industries Corporation Information
6.22.2 Sun Pharmaceutical Industries Pregabalin Description and Business Overview
6.22.3 Sun Pharmaceutical Industries Pregabalin Sales, Revenue and Gross Margin (2018-2024)
6.22.4 Sun Pharmaceutical Industries Pregabalin Product Portfolio
6.22.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.23 CTX Life Sciences
6.23.1 CTX Life Sciences Corporation Information
6.23.2 CTX Life Sciences Pregabalin Description and Business Overview
6.23.3 CTX Life Sciences Pregabalin Sales, Revenue and Gross Margin (2018-2024)
6.23.4 CTX Life Sciences Pregabalin Product Portfolio
6.23.5 CTX Life Sciences Recent Developments/Updates
6.24 Srini Pharmaceuticals
6.24.1 Srini Pharmaceuticals Corporation Information
6.24.2 Srini Pharmaceuticals Pregabalin Description and Business Overview
6.24.3 Srini Pharmaceuticals Pregabalin Sales, Revenue and Gross Margin (2018-2024)
6.24.4 Srini Pharmaceuticals Pregabalin Product Portfolio
6.24.5 Srini Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pregabalin Industry Chain Analysis
7.2 Pregabalin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pregabalin Production Mode & Process
7.4 Pregabalin Sales and Marketing
7.4.1 Pregabalin Sales Channels
7.4.2 Pregabalin Distributors
7.5 Pregabalin Customers
8 Pregabalin Market Dynamics
8.1 Pregabalin Industry Trends
8.2 Pregabalin Market Drivers
8.3 Pregabalin Market Challenges
8.4 Pregabalin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Pregabalin Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Pregabalin Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Pregabalin Market Competitive Situation by Manufacturers in 2022
Table 4. Global Pregabalin Sales (K MT) of Key Manufacturers (2018-2024)
Table 5. Global Pregabalin Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Pregabalin Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Pregabalin Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Pregabalin Average Price (USD/MT) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Pregabalin, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Pregabalin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pregabalin, Product Type & Application
Table 12. Global Key Manufacturers of Pregabalin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pregabalin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pregabalin as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pregabalin Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 17. Global Pregabalin Sales by Region (2018-2024) & (K MT)
Table 18. Global Pregabalin Sales Market Share by Region (2018-2024)
Table 19. Global Pregabalin Sales by Region (2024-2034) & (K MT)
Table 20. Global Pregabalin Sales Market Share by Region (2024-2034)
Table 21. Global Pregabalin Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Pregabalin Revenue Market Share by Region (2018-2024)
Table 23. Global Pregabalin Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Pregabalin Revenue Market Share by Region (2024-2034)
Table 25. North America Pregabalin Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 26. North America Pregabalin Sales by Country (2018-2024) & (K MT)
Table 27. North America Pregabalin Sales by Country (2024-2034) & (K MT)
Table 28. North America Pregabalin Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Pregabalin Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Pregabalin Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Pregabalin Sales by Country (2018-2024) & (K MT)
Table 32. Europe Pregabalin Sales by Country (2024-2034) & (K MT)
Table 33. Europe Pregabalin Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Pregabalin Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Pregabalin Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Pregabalin Sales by Region (2018-2024) & (K MT)
Table 37. Asia Pacific Pregabalin Sales by Region (2024-2034) & (K MT)
Table 38. Asia Pacific Pregabalin Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Pregabalin Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Pregabalin Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Pregabalin Sales by Country (2018-2024) & (K MT)
Table 42. Latin America Pregabalin Sales by Country (2024-2034) & (K MT)
Table 43. Latin America Pregabalin Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Pregabalin Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Pregabalin Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Pregabalin Sales by Country (2018-2024) & (K MT)
Table 47. Middle East & Africa Pregabalin Sales by Country (2024-2034) & (K MT)
Table 48. Middle East & Africa Pregabalin Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Pregabalin Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Pregabalin Sales (K MT) by Type (2018-2024)
Table 51. Global Pregabalin Sales (K MT) by Type (2024-2034)
Table 52. Global Pregabalin Sales Market Share by Type (2018-2024)
Table 53. Global Pregabalin Sales Market Share by Type (2024-2034)
Table 54. Global Pregabalin Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Pregabalin Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Pregabalin Revenue Market Share by Type (2018-2024)
Table 57. Global Pregabalin Revenue Market Share by Type (2024-2034)
Table 58. Global Pregabalin Price (USD/MT) by Type (2018-2024)
Table 59. Global Pregabalin Price (USD/MT) by Type (2024-2034)
Table 60. Global Pregabalin Sales (K MT) by Application (2018-2024)
Table 61. Global Pregabalin Sales (K MT) by Application (2024-2034)
Table 62. Global Pregabalin Sales Market Share by Application (2018-2024)
Table 63. Global Pregabalin Sales Market Share by Application (2024-2034)
Table 64. Global Pregabalin Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Pregabalin Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Pregabalin Revenue Market Share by Application (2018-2024)
Table 67. Global Pregabalin Revenue Market Share by Application (2024-2034)
Table 68. Global Pregabalin Price (USD/MT) by Application (2018-2024)
Table 69. Global Pregabalin Price (USD/MT) by Application (2024-2034)
Table 70. ZCL Chemicals Corporation Information
Table 71. ZCL Chemicals Description and Business Overview
Table 72. ZCL Chemicals Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 73. ZCL Chemicals Pregabalin Product
Table 74. ZCL Chemicals Recent Developments/Updates
Table 75. Olon S.p.A. Corporation Information
Table 76. Olon S.p.A. Description and Business Overview
Table 77. Olon S.p.A. Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 78. Olon S.p.A. Pregabalin Product
Table 79. Olon S.p.A. Recent Developments/Updates
Table 80. AASraw Biochemical Technology Corporation Information
Table 81. AASraw Biochemical Technology Description and Business Overview
Table 82. AASraw Biochemical Technology Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 83. AASraw Biochemical Technology Pregabalin Product
Table 84. AASraw Biochemical Technology Recent Developments/Updates
Table 85. Changzhou Pharmaceutical Factory (CPF) Corporation Information
Table 86. Changzhou Pharmaceutical Factory (CPF) Description and Business Overview
Table 87. Changzhou Pharmaceutical Factory (CPF) Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 88. Changzhou Pharmaceutical Factory (CPF) Pregabalin Product
Table 89. Changzhou Pharmaceutical Factory (CPF) Recent Developments/Updates
Table 90. Almelo Pvt. Ltd. Corporation Information
Table 91. Almelo Pvt. Ltd. Description and Business Overview
Table 92. Almelo Pvt. Ltd. Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 93. Almelo Pvt. Ltd. Pregabalin Product
Table 94. Almelo Pvt. Ltd. Recent Developments/Updates
Table 95. Divi’s Laboratories Corporation Information
Table 96. Divi’s Laboratories Description and Business Overview
Table 97. Divi’s Laboratories Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 98. Divi’s Laboratories Pregabalin Product
Table 99. Divi’s Laboratories Recent Developments/Updates
Table 100. Angels Pharma Corporation Information
Table 101. Angels Pharma Description and Business Overview
Table 102. Angels Pharma Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 103. Angels Pharma Pregabalin Product
Table 104. Angels Pharma Recent Developments/Updates
Table 105. ARITE Pharmaceutical Corporation Information
Table 106. ARITE Pharmaceutical Description and Business Overview
Table 107. ARITE Pharmaceutical Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 108. ARITE Pharmaceutical Pregabalin Product
Table 109. ARITE Pharmaceutical Recent Developments/Updates
Table 110. BAL Pharma Corporation Information
Table 111. BAL Pharma Description and Business Overview
Table 112. BAL Pharma Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 113. BAL Pharma Pregabalin Product
Table 114. BAL Pharma Recent Developments/Updates
Table 115. Bazayan Corporation Information
Table 116. Bazayan Description and Business Overview
Table 117. Bazayan Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 118. Bazayan Pregabalin Product
Table 119. Bazayan Recent Developments/Updates
Table 120. Aurobindo Pharma Corporation Information
Table 121. Aurobindo Pharma Description and Business Overview
Table 122. Aurobindo Pharma Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 123. Aurobindo Pharma Pregabalin Product
Table 124. Aurobindo Pharma Recent Developments/Updates
Table 125. Hikal Corporation Information
Table 126. Hikal Description and Business Overview
Table 127. Hikal Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 128. Hikal Pregabalin Product
Table 129. Hikal Recent Developments/Updates
Table 130. Glenmark Life Sciences Corporation Information
Table 131. Glenmark Life Sciences Description and Business Overview
Table 132. Glenmark Life Sciences Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 133. Glenmark Life Sciences Pregabalin Product
Table 134. Glenmark Life Sciences Recent Developments/Updates
Table 135. Dongbang FTL Corporation Information
Table 136. Dongbang FTL Description and Business Overview
Table 137. Dongbang FTL Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 138. Dongbang FTL Pregabalin Product
Table 139. Dongbang FTL Recent Developments/Updates
Table 140. Teva Pharmaceutical Industries Corporation Information
Table 141. Teva Pharmaceutical Industries Description and Business Overview
Table 142. Teva Pharmaceutical Industries Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 143. Teva Pharmaceutical Industries Pregabalin Product
Table 144. Teva Pharmaceutical Industries Recent Developments/Updates
Table 145. Divi’s Laboratories Corporation Information
Table 146. Divi’s Laboratories Description and Business Overview
Table 147. Divi’s Laboratories Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 148. Divi’s Laboratories Pregabalin Product
Table 149. Divi’s Laboratories Recent Developments/Updates
Table 150. Chemo Iberica Corporation Information
Table 151. Chemo Iberica Description and Business Overview
Table 152. Chemo Iberica Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 153. Chemo Iberica Pregabalin Product
Table 154. Chemo Iberica Recent Developments/Updates
Table 155. Maps Laboratories Corporation Information
Table 156. Maps Laboratories Description and Business Overview
Table 157. Maps Laboratories Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 158. Maps Laboratories Pregabalin Product
Table 159. Maps Laboratories Recent Developments/Updates
Table 160. Laurus Labs Corporation Information
Table 161. Laurus Labs Description and Business Overview
Table 162. Laurus Labs Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 163. Laurus Labs Pregabalin Product
Table 164. Laurus Labs Recent Developments/Updates
Table 165. Zhejiang Huahai Pharmaceutical Corporation Information
Table 166. Zhejiang Huahai Pharmaceutical Description and Business Overview
Table 167. Zhejiang Huahai Pharmaceutical Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 168. Zhejiang Huahai Pharmaceutical Pregabalin Product
Table 169. Zhejiang Huahai Pharmaceutical Recent Developments/Updates
Table 170. Vasudha Pharma Chem Corporation Information
Table 171. Vasudha Pharma Chem Description and Business Overview
Table 172. Vasudha Pharma Chem Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 173. Vasudha Pharma Chem Pregabalin Product
Table 174. Vasudha Pharma Chem Recent Developments/Updates
Table 175. Sun Pharmaceutical Industries Corporation Information
Table 176. Sun Pharmaceutical Industries Description and Business Overview
Table 177. Sun Pharmaceutical Industries Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 178. Sun Pharmaceutical Industries Pregabalin Product
Table 179. Sun Pharmaceutical Industries Recent Developments/Updates
Table 180. CTX Life Sciences Corporation Information
Table 181. CTX Life Sciences Description and Business Overview
Table 182. CTX Life Sciences Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 183. CTX Life Sciences Pregabalin Product
Table 184. CTX Life Sciences Recent Developments/Updates
Table 185. Srini Pharmaceuticals Corporation Information
Table 186. Srini Pharmaceuticals Description and Business Overview
Table 187. Srini Pharmaceuticals Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 188. Srini Pharmaceuticals Pregabalin Product
Table 189. Srini Pharmaceuticals Recent Developments/Updates
Table 190. Key Raw Materials Lists
Table 191. Raw Materials Key Suppliers Lists
Table 192. Pregabalin Distributors List
Table 193. Pregabalin Customers List
Table 194. Pregabalin Market Trends
Table 195. Pregabalin Market Drivers
Table 196. Pregabalin Market Challenges
Table 197. Pregabalin Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pregabalin
Figure 2. Global Pregabalin Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Pregabalin Market Share by Type in 2022 & 2034
Figure 4. Tablet Product Picture
Figure 5. Capsule Product Picture
Figure 6. Oral Solution Product Picture
Figure 7. Global Pregabalin Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Pregabalin Market Share by Application in 2022 & 2034
Figure 9. Hospitals
Figure 10. Clinics
Figure 11. Others
Figure 12. Global Pregabalin Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 13. Global Pregabalin Market Size (2018-2034) & (US$ Million)
Figure 14. Global Pregabalin Sales (2018-2034) & (K MT)
Figure 15. Global Pregabalin Average Price (USD/MT) & (2018-2034)
Figure 16. Pregabalin Report Years Considered
Figure 17. Pregabalin Sales Share by Manufacturers in 2022
Figure 18. Global Pregabalin Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Pregabalin Players: Market Share by Revenue in 2022
Figure 20. Pregabalin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Pregabalin Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Figure 22. North America Pregabalin Sales Market Share by Country (2018-2034)
Figure 23. North America Pregabalin Revenue Market Share by Country (2018-2034)
Figure 24. U.S. Pregabalin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 25. Canada Pregabalin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 26. Europe Pregabalin Sales Market Share by Country (2018-2034)
Figure 27. Europe Pregabalin Revenue Market Share by Country (2018-2034)
Figure 28. Germany Pregabalin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. France Pregabalin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. U.K. Pregabalin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Italy Pregabalin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Russia Pregabalin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. Asia Pacific Pregabalin Sales Market Share by Region (2018-2034)
Figure 34. Asia Pacific Pregabalin Revenue Market Share by Region (2018-2034)
Figure 35. China Pregabalin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. Japan Pregabalin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. South Korea Pregabalin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. India Pregabalin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Australia Pregabalin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Taiwan Pregabalin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Indonesia Pregabalin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Thailand Pregabalin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Malaysia Pregabalin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Philippines Pregabalin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Latin America Pregabalin Sales Market Share by Country (2018-2034)
Figure 46. Latin America Pregabalin Revenue Market Share by Country (2018-2034)
Figure 47. Mexico Pregabalin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Brazil Pregabalin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Argentina Pregabalin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Middle East & Africa Pregabalin Sales Market Share by Country (2018-2034)
Figure 51. Middle East & Africa Pregabalin Revenue Market Share by Country (2018-2034)
Figure 52. Turkey Pregabalin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Saudi Arabia Pregabalin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. U.A.E Pregabalin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 55. Global Sales Market Share of Pregabalin by Type (2018-2034)
Figure 56. Global Revenue Market Share of Pregabalin by Type (2018-2034)
Figure 57. Global Pregabalin Price (USD/MT) by Type (2018-2034)
Figure 58. Global Sales Market Share of Pregabalin by Application (2018-2034)
Figure 59. Global Revenue Market Share of Pregabalin by Application (2018-2034)
Figure 60. Global Pregabalin Price (USD/MT) by Application (2018-2034)
Figure 61. Pregabalin Value Chain
Figure 62. Pregabalin Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed